Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27892095 | 0.80 | POLB (0.43) | ALDH1A1CHRNB2CHRNB4CHRNA4TSHR | |
| SCHEMBL21872358 | 0.78 | ALDH1A1 (0.39) | ALDH1A1CHRNB2CHRNB4CHRNA4TSHR | |
| SCHEMBL12916975 | 0.76 | ALDH1A1 (0.42) | ALDH1A1CHRNB2CHRNB4CHRNA4TSHR | |
| SCHEMBL13436390 | 0.76 | ALDH1A1 (0.37) | ALDH1A1CHRNB2CHRNB4CHRNA4TSHR | |
| SCHEMBL13974209 | 0.76 | ALDH1A1 (0.37) | ALDH1A1CHRNB2CHRNB4CHRNA4TSHR | |
| SCHEMBL18924022 | 0.74 | ALDH1A1 (0.40) | ALDH1A1CHRNB2CHRNB4CHRNA4TSHR | |
| SCHEMBL8700656 | 0.74 | — | — | |
| SCHEMBL501589 | 0.72 | TSHR (0.30) | TSHR | |
| SCHEMBL12916989 | 0.72 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL21872024 | 0.72 | CHRNB2 (0.38) | ALDH1A1CHRNB2CHRNB4CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8609677-B2 | Molecules for the photodynamic treatment of tumors and hyperplasias | Yagna Limited (GB) | 2013-12-17 | — | — | US | claimed |
| US-20130226136-A1 | Molecules for the Photodynamic Treatment of Tumors and Hyperplasias | HUMANITARIAN SCIENTIFIC LLC | 2013-08-29 | — | — | US | claimed |
| US-8410125-B2 | Sulfonated precursors of thymidine for the treatment of epithelial hyperplasias | Yagna Limited (GB) | 2013-04-02 | — | — | US | claimed |
| US-20110053965-A1 | SULFONATED PRECURSORS OF THYMIDINE FOR THE TREATMENT OF EPITHELIAL HYPERPLASIAS | ASKLEPIUS LIMITED (GB) | 2011-03-03 | — | — | US | claimed |
| WO-2009060186-A1 | SULFONATED PRECURSORS OF THYMIDINE FOR THE TREATMENT OF EPITHELIAL HYPERPLASIAS | ASKLEPUIS LIMITED (GB) | 2009-05-14 | — | — | WO | claimed |
| US-8609677-B2 | Molecules for the photodynamic treatment of tumors and hyperplasias | Yagna Limited (GB) | 2013-12-17 | — | — | US | disclosed |
| US-20130226136-A1 | Molecules for the Photodynamic Treatment of Tumors and Hyperplasias | HUMANITARIAN SCIENTIFIC LLC | 2013-08-29 | — | — | US | disclosed |
| US-8410125-B2 | Sulfonated precursors of thymidine for the treatment of epithelial hyperplasias | Yagna Limited (GB) | 2013-04-02 | — | — | US | disclosed |
| US-20110053965-A1 | SULFONATED PRECURSORS OF THYMIDINE FOR THE TREATMENT OF EPITHELIAL HYPERPLASIAS | ASKLEPIUS LIMITED (GB) | 2011-03-03 | — | — | US | disclosed |
| WO-2009060186-A1 | SULFONATED PRECURSORS OF THYMIDINE FOR THE TREATMENT OF EPITHELIAL HYPERPLASIAS | ASKLEPUIS LIMITED (GB) | 2009-05-14 | — | — | WO | disclosed |